H. Cortes-Funes, A. Brugarolas and M. Gosalvez, “Quelamycin: A Summary of Phase I Clinical Trials,” Cancer Chemoand Immunopharmacology Recent Results in Cancer Research, Vol. 74, 1980, pp. 200-206. doi:10.1007/978-3-642-81488-4_25

has been cited by the following article:

• TITLE: Reversal of Cancer by Dual Strategy?

  AUTHORS: Mario Gosalvez

  KEYWORDS: Cancer Reversal; Mitochondrial Filamentation; Personal Mobility Chronotherapy; Mitochondrial Glycolysis; Respiration; Anoxic and Fagocitic Tumoral Redoubts

  JOURNAL NAME: Journal of Cancer Therapy, Vol.4 No.2, April 12, 2013

  ABSTRACT: I present herewith a concise historic account of our development of the new technique for cancer therapy: Reversal of Cancer by Dual Strategy. This new method is based on the possible correction of the mitochondrial filamentation defect of tumors plus minor cytotoxicity addressed to the anoxic and fagocitic tumor’s redoubts, using the administration of the anticancer agents with a chrono-therapeutic emphasis on the patient’s mobility. Such methods probably will reach patients in the near future with the collaboration of private clinical trials mainly at least in the USA, Europe and Japan. Only the more essential references of this effort are provided.